Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)

Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) (real clinical drug)

active

Code	`27567911000001101`
Semantic tag	real clinical drug
Module	uk-clinical
Definition	defined
Effective time	20260506

Parents (3)

10363901000001102Actual medicinal product product
12221201000001100Incruse Ellipta product
27890611000001109Umeclidinium bromide 65micrograms/dose dry powder inhaler clinical drug

Children (0)

None (leaf concept).